These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25281403)

  • 41. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
    Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
    Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quercetin enhances adriamycin cytotoxicity through induction of apoptosis and regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase/c-Jun N-terminal kinase signaling in multidrug-resistant leukemia K562 cells.
    Chen FY; Cao LF; Wan HX; Zhang MY; Cai JY; Shen LJ; Zhong JH; Zhong H
    Mol Med Rep; 2015 Jan; 11(1):341-8. PubMed ID: 25339540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
    Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multi-drug-resistant cells enriched from chronic myeloid leukemia cells by Doxorubicin possess tumor-initiating-cell properties.
    Xin H; Kong Y; Jiang X; Wang K; Qin X; Miao ZH; Zhu Y; Tan W
    J Pharmacol Sci; 2013; 122(4):299-304. PubMed ID: 23903006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Reversal of multi-drug resistance in K562/A02 cells by small interference RNA of mdr1 gene].
    Peng Z; Xiao ZJ; Wang Y; Liu P; Cai YL; Feng WL; Han ZC
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):5-7. PubMed ID: 14990067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
    Pan J; Miao D; Chen L
    Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcription factor c-Jun activation represses mdr-1 gene expression.
    Miao ZH; Ding J
    Cancer Res; 2003 Aug; 63(15):4527-32. PubMed ID: 12907627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L).
    Perkins C; Kim CN; Fang G; Bhalla KN
    Blood; 2000 Feb; 95(3):1014-22. PubMed ID: 10648417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E.
    Ge Y; Cheng R; Zhou Y; Shen J; Peng L; Xu X; Dai Q; Liu P; Wang H; Ma X; Jia J; Chen Z
    Mol Cell Biochem; 2012 Sep; 368(1-2):17-25. PubMed ID: 22614784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia.
    Itoh M; Kitano T; Watanabe M; Kondo T; Yabu T; Taguchi Y; Iwai K; Tashima M; Uchiyama T; Okazaki T
    Clin Cancer Res; 2003 Jan; 9(1):415-23. PubMed ID: 12538495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression.
    Li H; Hui L; Xu W; Shen H; Chen Q; Long L; Zhu X
    Pharm Biol; 2012 Oct; 50(10):1233-40. PubMed ID: 22957792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucosylceramide synthase regulates the proliferation and apoptosis of liver cells in vitro by Bcl‑2/Bax pathway.
    Li JF; Zheng SJ; Wang LL; Liu S; Ren F; Chen Y; Bai L; Liu M; Duan ZP
    Mol Med Rep; 2017 Nov; 16(5):7355-7360. PubMed ID: 28944894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
    Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
    Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GMZ-1 is a podophyllotoxin derivative that suppresses growth and induces apoptosis in adriamycin-resistant K562/A02 cells through modulation of MDR1 expression.
    Cao B; Yang S; Li W; Chen H; Chen Y; Liu Y; Liu B
    Mol Med Rep; 2018 Jan; 17(1):474-478. PubMed ID: 29115592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
    Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of microRNA let-7f mediated the Adriamycin resistance in leukemia cell line.
    Cao YX; Wen F; Luo ZY; Long XX; Luo C; Liao P; Li JJ
    J Cell Biochem; 2020 Oct; 121(10):4022-4033. PubMed ID: 31793054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Knockdown of Alox5 gene promotes apoptosis of K562/ADM cells].
    Luo Y; Xu M; Gao W; Tao K
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1398-1403. PubMed ID: 29169426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of compound Zhe-Bei granule (CZBG) combined with doxorubicin on cell apoptosis and expression of related proteins in K562/A02 multidrug resistance tumor xenografts in mice].
    Chen XY; Zheng Z; Chen J; Li DY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1439-42. PubMed ID: 20030922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.